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Abstract 
Changes in QRS duration and pattern are regarded to reflect severe ischemia in acute coronary 
syndromes (ACS), and ventricular conduction blocks (VCBs) are recognized high-risk markers in 
both ACS and acute heart failure. Our aim was to evaluate the prevalence, temporal evolution, 
association with clinical and angiographic parameters, and impact on 1-year mortality of VCBs in 
ACS-related CS. Data of 199 patients with ACS-related CS from a prospective multinational cohort 
was evaluated with 12-lead ECG data from baseline and day 3. VCBs including LBBB, RBBB, 
RBBB and hemiblock, isolated hemiblocks, and unspecified intraventricular conduction delay 
(IVCD) were assessed. Fifty percent of patients had a VCB at baseline; these patients were older, 
had lower left ventricular function and had more often left main disease compared to those without 
VCB. One-year mortality was over two-fold in patients with VCB compared to those without VCB 
(68% vs. 32%, p<0.001). All types of VCBs at baseline were associated with increased mortality, 
and the predictive value of a VCB was independent of baseline variables and coronary angiography 
findings. Interestingly, 37% of the VCBs were transient, i.e. disappeared before day 3. However, 1-
year mortality was much higher in these patients (69%) compared to patients with persistent (38%) 
or no VCB (15%, p<0.001). Indeed, a transient VCB was a strong independent predictor of 1-year 
mortality (adjusted HR 4.4 95% CI 2.0-9.6). In conclusion, our findings propose that any VCB at 
baseline ECG, even if transient, identifies very early patients at particularly high mortality risk in 
ACS-related CS. 
 
Key words: acute coronary syndromes, acute myocardial infarction, cardiogenic shock, acute heart 
failure, ECG/electrocardiogram, ventricular conduction block 
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Introduction 
Cardiogenic shock (CS) is the most severe complication of acute myocardial infarction (AMI) and 
is associated with high short-term mortality, despite advances in reperfusion therapy and modern 
intensive care
1,2
. In AMI, the incidence of CS increases from 5-8% up to 12-19% in the presence of 
a bundle branch block
1,3-5
, especially with right bundle branch block (RBBB) 
5,6
. Changes in the 
QRS duration and pattern in addition to ST segment deviations are regarded to reflect more severe 
ischemia and faster progression of irreversible myocardial necrosis than ST segment deviations 
alone
7,8
.  Conduction disturbances may be dynamic changes in the ECG, and high frequency of 
block resolution has been reported in non-CS AMI with associated survival benefit
6,9,10
. Despite the 
ominous nature of ventricular conduction blocks (VCBs), there are few studies focused in CS. Most 
data are derived from broader AMI cohorts, focused on bundle branch blocks, or are from the 
thrombolytic era 
5,11,12
. While RBBB seems to predict mortality also in CS
5,11
, data on other types of 
VCBs is scarce. Therefore we investigated the prevalence and temporal evolution of VCBs, and 
their impact on mortality in CS complicating acute coronary syndromes (ACS) in a contemporary 
multinational cohort of CS with serial ECG recordings. Our hypothesis was that VCBs are 
associated with increased mortality. 
 
Methods 
Data from two independent prospectively collected cohorts were combined for this 
analysis. Patients with ACS (n=155) from the prospective European multinational cohort on CS, the 
CardShock study, and 44 patients from a prospective observational study of CS complicating AMI 
at the Brno University Hospital, Czech republic were included. Detailed description of the study 
designs and primary results of these studies have been previously published 
13,14
. Recruitment 
period for CardShock study patients was form October 2010 to December 2012, and for the 
additional patients from Brno from June 2005 until January 2012. For both cohorts CS was defined 
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as hypotension with systolic blood pressure <90 mmHg lasting for 30 min despite fluid 
administration or need for inotropic or vasopressor therapy, and 1 or more signs of organ 
hypoperfusion (cool extremities, confusion or altered mental status, oliguria <0.5ml/kg/h for the 
previous six hours, blood lactate >2mmol/l). All patients had echocardiography at baseline. 
Exclusion criteria were shock caused by on-going hemodynamically significant arrhythmia and 
shock after cardiac or non-cardiac surgery. Seventeen patients were excluded due to missing 
baseline ECG and six patients were excluded due to only ventricular paced complexes or 
idioventricular rhythm in the baseline ECG. This resulted in a final study cohort of 199 patients. 
ECG at day 3 was available in 134 (80% of those alive) patients. High sensitive troponin T (hs-
TnT), (Elecsys high-sensitive Troponin, Roche Diagnostics) and N-terminal pro-natriuretic peptide 
(NT-proBNP) (Elecsys, NT-proBNP; Roche Diagnostics) were measured at a central laboratory 
(ISLAB, Kuopio, Finland), and soluble ST2 (sST2) was measured with Presage sST2 Assay 
(Critical Diagnostics, San Diego, CA) at INSERM UMR-S 942 (Paris, France)
15
 from 138 patients 
from the CardShock cohort. NT-proBNP was measured locally for the remaining 44 patients from 
Brno. Peak values of hs-TnT and NT-proBNP were determined from serial samples taken at 12-
hour intervals during the first 48 hours after study inclusion. Vital status during follow-up of 1 year 
was determined through direct contact with the patient or next of kin, or through population and 
hospital registers. Two patients were lost to follow-up; in the mortality analyses these cases were 
censored at the time of hospital discharge. Both studies were approved by local ethics committees at 
the participating centers and conducted in accordance with the declaration of Helsinki. Written 
consent was obtained from the patients or next of kin. 
ECGs at baseline and on day 3 were analyzed for this study. In case of multiple ECG 
recordings at baseline, the closest ECG to the detection of shock with intrinsic (not paced) 
ventricular complexes was preferred. Rhythms and QRS configuration were manually analyzed by 
3 independent researchers. The QRS duration was measured automatically; in case of discrepancy 
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of data, manual assessment was prioritized. Complete LBBB and RBBB were identified by standard 
criteria
16
. Left anterior hemiblock (LAHB) was defined as QRS axis between -45 and -90 degrees, 
qR/R in leads I and aVL, rS in lead II, III and aVF, and QRS <120ms if without concomitant 
RBBB. Left posterior hemiblock (LPHB) was defined as QRS axis > 90 degrees, qR in lead III and 
rS complex in lead I, and as QRS <120ms, if without concomitant RBBB. Unspecified 
intraventricular conduction delay (IVCD) was defined as QRS duration ≥110 ms not fulfilling the 
criteria of either bundle branch block or hemiblock
17,18
.  Temporal evolution of conduction pattern 
(appearance or resolution of block) from baseline to day 3 was assessed, and group comparisons 
were performed with those who did not have block at baseline and on day 3. Patients who died 
before day 3 or who lacked day 3 ECG were excluded from this analysis. To investigate the pre-
existence of the block, a retrospective search of the previous ECGs was performed for those patients 
with a VCB in the baseline ECG from the 3 largest study centers (Helsinki, Brno, Barcelona). 
Previous ECG was available in 42% (30/72) of these patients. 
Results are shown as numbers and percentages (%), means with standard deviation (SD) 
or medians with interquartile range (IQR) for variables not normally distributed. Dichotomous 
variables were compared using the chi-square analysis and continuous variables using 1-way 
ANOVA and Kruskal-Wallis tests. For continuous variables, each type of VCB was compared to 
those with no VCB as pairwise comparisons using Dunnett’s methods or Mann-Whitney U-test with 
Bonferroni corrections as appropriate. Mortality analyses were performed using Kaplan–Meier 
(KM) survival curves and Cox proportional hazard ratios (HR). Multivariable analyses were 
performed using two separate models. Applying a Cox Regression backward selection approach, 
candidate baseline covariables available in >90% of study population (age, gender, history of 
hypertension, diabetes, hyperlipidemia, previous myocardial infarction, previous PCI/CABG, 
peripheral artery disease, history of TIA/ stroke, history of atrial fibrillation, chronic obstructive 
pulmonary disease (COPD), current smoking status, body mass index (BMI), systolic blood 
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pressure (SBP), heart rate, left ventricular ejection fraction (LVEF), and estimated glomerular 
filtration rate (eGFR)) were assessed. Significant associates together with age and gender were 
selected for the final model. The final model included age, gender, history of hyperlipidemia, 
COPD, previous PCI or CABG, SBP, LVEF, and eGFR. To investigate the association of the 
blocks and their temporal evolution with localization and extent of coronary artery disease, a second 
model was performed with similar approach for the findings in the coronary angiography: 3-vessel 
disease, left main stenosis, infarct-related artery (left main / left anterior descending artery or its 
branches / left circumflex artery or its branches/ right coronary artery or its branches), percutaneous 
coronary intervention (PCI) of the infarct-related artery (yes/no), initial Thrombolysis in myocardial 
infarction (TIMI) flow 0-1 (yes/no), and final (post-PCI) TIMI flow 3 (yes/no). If PCI was not 
performed, initial and final TIMI flow were the same. The final model 2 included: 3-vessel disease, 
infarct-related artery, and final TIMI flow 3. Patients with no VCB was used as reference category. 
HRs are shown with 95% confidence intervals (CI). The statistical analyses were performed with 
SPSS 21 statistical software (IBM Corp, Armonk, NY, USA). 
 
Results 
Mean age of the 199 studied patients was 66 years (range 36-90); 75% (n=150) were 
men. Sixty-two patients (31 %) had history of ischemic heart disease. Median QRS duration was 
102 ms (IQR 88-125 ms). Half of the patients (n=100, 50%) had a VCB in baseline ECG. LBBB 
was found in 8 patients and isolated RBBB in 10 patients. In addition, 18 patients had concomitant 
RBBB and hemiblock (8 with RBBB+LAHB and 8 with RBBB+LPHP). An isolated hemiblock 
was found in 32 patients (25 with LAHB and 7 with LPHB) and IVCD in 32 patients (Figure 1). 
Overall, patients with a VCB were older and had lower LVEF than patients without VCB. Baseline 
characteristics of the patients with different types of VCBs are shown in Table 1. In the coronary 
angiography, patients with a VCB had more often left main as the infarct-related artery compared to 
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patients without VCB; this finding came from patients with RBBB+hemiblock, isolated hemiblock 
and IVCD. Patients with a VCB had higher peak NT-proBNP levels than those without VCB. Peak 
hs-TnT levels were particularly high in patients with RBBB+hemiblock and in those with an 
isolated hemiblock (Table 2). 
Patients with any VCB had more than two-fold 1-year mortality compared to those 
without VCB (68% vs. 32%, P<0.001, Figure 2). Presence of any VCB was an independent 
predictor of 1-year mortality (adjusted HR for baseline covariates 2.0, 95% CI 1.2 – 3.2, p = 0.004). 
Their association with increased mortality was also independent of the coronary angiogram findings 
(adjusted HR 2.0, 95% CI 1.2 – 3.2, p = 0.006). Increasing QRS width as such was also associated 
with increased mortality (HR 1.1, 95% CI 1.0-1.2, p = 0.002 for each 10ms increase in QRS 
duration), but the association was not significant after adjusting for covariates. Each type of VCB in 
baseline ECG was associated with increased 1-year mortality in univariate analysis. Each VCB also 
remained at least a nearly independent predictor (p < 0.10) of mortality in the two multivariate 
models, except for IVCD when adjusted for coronary angiogram findings (Figure 3).  
Thirty-two (16%) patients died within the first 3 days. Of the patients alive on the third 
day, 45% (n=60) had no conduction block either at baseline or day 3 ECG (= no block). In 25% 
(n=33) of patients, the same type of VCB was present in the baseline ECG and in day 3 ECG (= 
persistent block), while in 19% (n=26) the block present at baseline had disappeared at day 3 (= 
transient block). In addition, in 10 patients the block present in baseline ECG had changed to 
another type of block, and 5 patients without a block in baseline ECG had a newly appeared block 
in day 3 ECG. Table 3 shows the evolution of each type of baseline VCB. Patients with a persistent 
block were older and had higher peak NT-proBNP levels compared to those who never had any 
block, while patients with a transient block had particularly high peak hs-TnT and peak sST2 levels 
(Supplementary Table 1). Interestingly, 1-year mortality was highest (69%) in those with a transient 
block (Figure 4). The association of transient block with 1-year mortality was strong and 
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independent of baseline covariates (adjusted HR 4.4, 95% CI 2.0 – 9.6, p < 0.001) and coronary 
angiography findings (adjusted HR 4.6, 95% CI 2.0 – 10.6, p < 0.001) (Supplementary Table 2). 
 In retrospectively searched previous ECGs (available in 42% of searched patients), the 
baseline block was present in the pervious ECG in 40% (4/10) of those with persistent block, in 
20% (1/5) in those in which the block changed, and in none (0/10) of those with a transient block. 
The 1-year mortality did not statistically differ in the patients with pre-existing block (n= 6, 
mortality 86%) from those with a new-appearing block (n=24, mortality 58%, p = 0.34). 
 
Discussion 
The present study shows that half of patients with ACS-related CS presented with a 
VCB, and these patients had over 2-fold 1-year mortality compared to patients without VCB. Each 
type of VCB at baseline ECG was associated with increased mortality, and the predictive value of 
any VCB at baseline for 1-year mortality was independent of baseline variables and of coronary 
angiography findings. In patients surviving until day 3, a third of the VCB seen at baseline had 
disappeared. However, these patients had the highest 1-year mortality.   
Overall, the prevalence of the bundle branch blocks seen in our patients was 
comparable to the few earlier studies on CS
5,12
, but except for LBBB, higher than reported in 
patients with AMI or acute heart failure
4,19-21
. Higher mortality of CS patients with RBBB (with or 
without concomitant hemiblock) has been reported
5,11
. We broadened this observation by analyzing 
all types of VCBs in CS. Although patients with a VCB were older, had more depressed left 
ventricular function and more critical coronary artery disease compared to those with normal 
conduction, the predictive value of any VCB at baseline was independent of baseline 
characteristics, coronary angiography findings, and of revascularization success.  
When looking at the type of VCB, RBBB was a predictor of mortality in line with 
earlier studies
5,11
. In addition, we showed that in most cases RBBB coexisted with a hemiblock, and 
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the combination was an independent predictor of increased mortality. Patients with isolated RBBB 
had relatively good left ventricular function, as described earlier in CS
5
, while those with RBBB 
and hemiblock had poor left ventricular function and particularly high peak troponin levels 
suggesting large myocardial injury. As for LBBB, these patients were older and had high 
prevalence of comorbidities together with poor left ventricular function, but relatively low troponin 
levels suggesting previously diseased myocardium. White and coworkers
12
 found in The Should We 
Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial that 
prolonged QRS (with or without bundle branch block) predicts mortality in CS. However, to the 
best of our knowledge, our study was the first to investigate the characteristics of hemiblocks and 
IVCD separately in CS. Both isolated hemiblock and IVCD were prevalent, and both were 
associated with poor outcome. The association of IVCD with increased mortality was lost after 
adjustment for coronary angiogram findings and revascularization success, in line with findings 
from the SHOCK trial, in which QRS prolongation (with or without bundle branch block) 
independently predicted mortality only in the initially medically treated CS patients and not in those 
randomized to emergent revascularization. As QRS prolongation associates with infarct 
transmurality, the salvage of myocardium by emergent revascularization was suggested to have 
eliminated the effect of QRS prolongation on outcome in revascularized patients
12
. In addition to 
increased QRS duration in severe myocardial ischemia, as the regional conduction is slowed the 
QRS amplitude may be affected, leading to in a shift of the electrical axis that may result in a 
hemiblock configuration.
7,22,23
 These phenomena may explain the observation that the myocardial 
infarction was related to left main coronary artery relatively often in those with a hemiblock (with 
or without RBBB) and IVCD, and the particularly high troponin levels seen in the presence of a 
hemiblock.  
In our study in patients surviving until day 3, a third of the blocks were transient and 
an additional 15% of the blocks had changed from baseline to day 3, comparable to what was 
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described earlier in CS 
5
.  Interestingly, in our cohort, the highest mortality at 1 year was observed 
in those with a transient block, and transient block was a strong independent predictor of mortality. 
Data are scarce on block evolution and its effect on survival in CS, but in revascularized AMI 
patients persistent conduction blocks have been described to associate with higher mortality than 
transient blocks 
3,9,10,19
. However, the independent associations of VCBs with disease severity and 
poor outcome in AMI have been shown to mainly apply to new-onset blocks
4,6
. Since blocks of 
recent onset are more likely to revert to normal conduction than pre-existent blocks
19,24,25
, the 
transient VCBs in our cohort probably were of new-onset, thus reflecting the severity of myocardial 
damage in the acute phase. This assumption is supported by particularly high peak troponin and 
sST2 levels in patients with a transient block, and indeed, none of the transient blocks were present 
in the patients’ previous ECGs. Moreover, many of the transient or changing VCBs were 
hemiblocks (with or without RBBB) or IVCDs. Transient QRS prolongation is a well-known 
phenomenon in ischemia
26,27
, and slowed myocardial conduction due to severe ischemia may also 
lead to an axis deviation comparable of a hemiblock even in absence of true injury of the 
fascicles
22,23
, thus resulting in reversible QRS changes. Changes in the QRS duration and 
morphology in addition to ST segment deviations reflect more severe myocardial ischemia and 
faster progression of irreversible myocardial necrosis compared to sole ST deviations
7,8
. Thus, our 
findings in patients with ACS-related CS suggest that VCBs at baseline, even if transient, are a very 
early sign of extensive myocardial suffering carrying particularly high mortality risk.  
The limited size of the cohort results in small number of patients with different types 
of VCBs, therefore our results should be interpreted with caution. High early mortality typical for 
CS further decreased the patients with serial ECGs available. Nevertheless, this prospective cohort 
is one of the largest specifically studying CS patients with serial ECGs. Unfortunately, we did not 
have data on the previous EGCs for all patients even after a retrospective search. This reflects, 
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however, the real world clinical practice, as CS patients are treated in tertiary care centers that may 
have limited access to previous patient data in the acute setting. 
Our findings suggest that in patients with ACS-related CS, presentation with any VCB 
implies particularly high mortality risk, and later reversal of blocks does not abolish their negative 
impact on mortality. Patients with any VCB in the baseline ECG should be treated as particularly 
high-risk patients with corresponding therapeutic approach. 
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Figure 1. Prevalence of ventricular conduction blocks (VBSs) in the baseline electrocardiogram in 
the 199 studied patients. IVCD = intraventricular conduction delay, LBBB = left bundle branch 
block, RBBB = right bundle branch block. 
 
Figure 2. One-year survival of patients with any or no ventricular conduction block (VCB) in 
baseline electrocardiogram. P-value with Log-Rank test. 
 
Figure 3. Unadjusted and adjusted Hazard Ratios for 1-year mortality of patients with each type of 
ventricular conduction block in baseline electrocardiogram. IVCD = intraventricular conduction 
delay, LBBB = left bundle branch block, RBBB = right bundle branch block. 
 
Figure 4. One-year survival of patients with each type of temporal evolution (from baseline to 3 
days) of ventricular conduction blocks. All patients who died before day 3 were censored from this 
analysis. Block stayed vs. no block p = 0.011, Block disappeared vs. no block p < 0.001, block 
changed vs. no block p = 0.007, Block appeared vs. no block p = 0.18. 
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Table 1. Baseline characteristics of patients with each type of ventricular conduction block (VCB); n (%), mean ± standard deviation, or median 
(interquartile range). P-value for trend within groups of no VCB, LBBB, RBBB, RBBB + hemiblock, hemiblock, and IVCD. *: p < 0.05 
compared to patients with no VCB. BPM = beats per minute, COPD = chronic obstructive pulmonary disease, eGFR = estimated glomerular 
filtration rate, IVCD = intraventricular conduction delay, LBBB = left bundle branch block, LVEDD = left ventricular end-diastolic diameter, 
LVEF = left ventricular ejection fraction, RBBB = right bundle branch block, TAPSE = tricuspid annular plane systolic excursion. 
+
 = Data 
available only from CardShock cohort. 





















p for trend 
 
 
Age (years) 65 ± 11 69 ± 11* 75 ± 6* 72 ± 11 65 ± 12 70 ± 12* 67 ± 11 0.010 
Men 73 (74%) 77 (77%) 5 (63%) 6 (60%) 17 (94%) 22 (69%) 27 (84%) 0.67 
Hypertension 59 (60%) 60 (59%) 7 (88%) 4 (40%) 11 (61%) 16 (50%) 22 (69%) 0.26 
Diabetes mellitus 27 (27%) 39 (39%) 5 (63%)* 5 (50%) 4 (22%) 11 (34%) 14 (44%) 0.13 
Coronary artery disease 28 (28%) 34 (34%) 5 (63%)* 3 (20%) 6 (33%) 7 (22%) 13 (41%) 0.24 
Previous myocardial 
infarction 23 (23%) 22 (22%) 4 (50%) 2 (20%) 4 (22%) 5 (16%) 7 (22%) 0.49 
Chronic heart failure
+
 6 (8%) 8 (10%) 2 (40%)* 1 (17%) 2 (14%) 1 (3%) 2 (7%) 0.16 
COPD 3 (3%) 9 (9%) 0 (0%) 0 (0%) 3 (17%)* 3 (9%) 3 (9%) 0.18 
































Heart rate (BPM) 87 (68-110) 93 (73-110) 89 (59-116) 92 (68-110) 87 (54-102) 99 (82-111) 91 (75-110) 0.85 
Sinus rhythm 79 (80%) 74 (74%) 8 (100%) 6 (60%) 16 (89%) 25 (78%) 19 (59%)* 0.042 
LVEF (%) 38 ± 14 33 ± 14* 26 ± 16 47 ± 15 30 ± 12 31 ± 14 34 ± 13 0.006 





 17 ± 5 18 ± 4 20 ± 2 12 ± 7 18 ± 4 18 ± 4 17 ± 5 0.21 
Lactate (mmol/L)
 
(n=166) 2.5 (1.5-5.1) 3.3 (2.2-7.0)* 3.4 (3.1-3.7) 8.5 (4.2-13.3)* 2.7 (1.9-7.6) 4.1 (2.6-7.6)* 2.4 (1.6-4.9) 0.002 
eGFR (ml/min/1.72m
2
) 67 ± 29 57 ± 27* 50 ± 20 49 ± 24 62 ± 24 53 ± 24 63 ± 32 0.073 
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Table 2. Coronary angiography findings, revascularization, and biochemistry in patients with each type of ventricular conduction block (VCB); n 
(%) or median (interquartile range). P-value for trend within groups of no VCB, LBBB, RBBB, RBBB + hemiblock, hemiblock, and IVCD. *: p 
< 0.05 compared to patients with no VCB. For IVCD, LBBB, and RBBB please refer to Table 1. CABG = coronary artery bypass surgery, LAD 
= left anterior descending artery, LCX = left circumflex artery, PCI =  percutaneous coronary intervention, RCA = right coronary artery, TIMI = 
initial thrombolysis in myocardial infarction. 
+


























for trend         
 
Left main stenosis 9 (10%) 22 (24%)* 1 (17%) 0 (0%) 4 (24%) 11 (34%)* 6 (21%) 0.023 
Three-vessel disease 35 (37%) 26 (29%) 4 (67%) 3 (43%) 4 (24%) 9 (29%) 6 (21%) 0.23 
Infarct-related artery:         
   Left main 4 (4%) 18 (20%)* 0 0 3 (18%)* 9 (28%)* 6 (21%)* 0.003 
   LAD/branches 40 (42%) 33 (36%) 1 (17%) 3 (38%) 9 (53%) 12 (38%) 8 (28%) 0.47 
   LCX/branches 17 (18%) 14 (15%) 1 (17%) 1 (13%) 2 (12%) 3 (9%) 7 (24%) 0.72 
   RCA/branches 31 (32%) 21 (23%) 3 (50%) 4 (50%) 3 (18%) 6 (19%) 5 (17%) 0.15 
PCI to infarct-related 
artery 85 (86%) 86 (86%) 6 (75%) 8 (80%) 17 (94%) 30 (94%) 25 (78%) 0.37 
Initial TIMI 0-1 77 (84%) 79 (88%) 5 (83%) 7 (88%) 14 (82%) 26 (87%) 27 (93%) 0.87 
Final TIMI 3 67 (80%) 57 (67%) 5 (83%) 6 (75%) 12 (71%) 19 (66%) 15 (60%) 0.38 
Thrombolysis
+ 13 (18%) 4 (5%)* 0 0 2 (14%) 1 (3%) 1 (4%) 0.16 


































































Table 3. Temporal evolution of blocks from baseline ECG (left column) to day 3 ECG (top row), in patients alive on day three with day 3 ECG 
available (N=134), n (%). At the columns at the right hand side there are the number of patients who died before day 3 or did not have day 3 
ECG available (NA). For IVCD, LBBB, RBBB, and VCB please refer to Table 1.  
  No block Block stayed Block disappeared Block changed Block appeared Died before day 3 Alive, ECG2 NA 
No VCB 60 (92%) 0 0 0 5 (8%) 12 22 
LBBB 0 5 (83%) 0 1 (17%) 0 1 1 
RBBB 0 5 (83%) 1 (17%) 0 0 4 0 
RBBB+hemiblock 0 6 (38%) 6 (38%) 4 (25%) 0 1 1 
Hemiblock 0 10 (56%) 7 (39%) 1 (6%) 0 8 6 
IVCD 0 7 (30%) 12 (52%) 4 (17%) 0 6 3 
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